1. Society for Endocrinology Meeting, March 2007 Is Open Access financially viable and does it achieve wider dissemination? Martin Richardson Managing Director Oxford Journals

2. Society for Endocrinology Meeting, March 2007 Why we are experimenting with Open Access Our experiments are designed to discover whether Open Access models can achieve wider, more cost effective dissemination than subscription- based models But in order to be widely adopted Open Access models will also need to be financially viable and accepted by authors and research funders

3. Society for Endocrinology Meeting, March 2007 The need to collect real data on: Effect of OA on usage Financial sustainability Author response An evidence-based approach

4. Society for Endocrinology Meeting, March 2007 Optional open access – Oxford Open Full open access – Nucleic Acids Research Sponsored Open Access –Evidence Based Alternative & Complementary Medicine Open Access – three financial models

5. Society for Endocrinology Meeting, March 2007 54 Journals participating across a broad range of subjects Author charges £800/£1500 depending on whether author based at subscribing institution Subscription prices to be adjusted in proportion to % of pages published OA in prior year Model 1: Optional Open Access

6. Society for Endocrinology Meeting, March 2007 Model 2: Full Open Access Author charge of £1250 per paper Discounted charge of 50% for authors from institutions with “institutional membership” Institutional membership rate = £1900 Free or reduced rates for authors from developing countries Waivers available for other authors in case of financial hardship

7. Society for Endocrinology Meeting, March 2007 New Journal launched 2004 High proportion of authors from developing countries More than 50% non-research articles Model 3: Sponsored Open Access

8. Society for Endocrinology Meeting, March 2007 Print version sold on subscription Online version Open Access for 2004-7 No author charges Fixed costs covered by sponsorship grant From 2008, will move to subscription-based model for non-research articles Author charges may be introduced in the future Model 3: Sponsored Open Access

9. Society for Endocrinology Meeting, March 2007 Do authors want OA? Oxford Open uptake 2006

10. Society for Endocrinology Meeting, March 2007 NAR: Daily article views for 2003-2005 Does OA increase usage? Source: Ciber study, 2006

11. Society for Endocrinology Meeting, March 2007 Does OA increase usage? All articles - 1st 12 months 0 100 200 300 400 500 600 0123456789101112 Months after publication Mean access per article 21s 21oa 22s 22oa Source: LISU Survey 2006 Bioinformatics: downloads

12. Society for Endocrinology Meeting, March 2007 Is OA financially viable? NAR: Income per article

13. Society for Endocrinology Meeting, March 2007 Nucleic Acids Research Sources of funding for paying OA charges

14. Society for Endocrinology Meeting, March 2007 When given the choice, most authors decide not to take up OA option if asked to pay OA seems to generate additional access, but the amount is variable from journal to journal OA does not yet seem to be financially viable without some kind of subsidy Some Tentative Conclusions…..

15. Society for Endocrinology Meeting, March 2007 CIBER -Usage analysis of journals participating in Oxford Open with uptake of 10% or more LISU-Usage/citation analysis of NAR, Bioinformatics and Journal of Experimental Botany. OUP-Continue to monitor financial impact of different OA models. Experimenting with Open Access: Next Steps

16. Society for Endocrinology Meeting, March 2007 Further Information Description of Oxford Journals OA models, FAQ’s and titles participating www.oxfordjournals.org/oxfordopen/ Report of one-day conference presenting results of Oxford OA experiments www.oxfordjournals.org/news/oa_report.pdf CIBER/UCL Centre for Publishing www.publishing.ucl.ac.uk/research.html LISU www.lboro.ac.uk/departments/dils/lisu/index.html

17. JISC Conference on OA, September 2006 For further information, please contact Martin Richardson Managing Director Tel: +44 (0) 1865 353780 Fax: +44 (0) 1865 353200